Cellebrite Stock Upgraded by BofA: Buy Now!
Bank of America Securities upgrades Cellebrite stock to Buy, increasing price target to $12. Improved business momentum and strong market ...
- Latest
- Trending
Bank of America Securities upgrades Cellebrite stock to Buy, increasing price target to $12. Improved business momentum and strong market ...
Connect Biopharma has appointed James Zuie-chin Huang to its Board of Directors. Huang brings over 30 years of biotech experience ...
Anixa Biosciences advances Phase 1 clinical trial for ovarian cancer therapy, increasing dosage and showing promising results. Market responds positively ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.